Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin.
The tissue distribution and function of hemoglobin or myoglobin are well known; however, a newly found cytoglobin (CYGB), which also belongs to the globin family, remains to be characterized. To assess its expression in human malignancies, we sought to screen a number of cell lines originated from m...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3983271?pdf=render |
_version_ | 1811237188013129728 |
---|---|
author | Yoshihiko Fujita Satoshi Koinuma Marco A De Velasco Jan Bolz Yosuke Togashi Masato Terashima Hidetoshi Hayashi Takuya Matsuo Kazuto Nishio |
author_facet | Yoshihiko Fujita Satoshi Koinuma Marco A De Velasco Jan Bolz Yosuke Togashi Masato Terashima Hidetoshi Hayashi Takuya Matsuo Kazuto Nishio |
author_sort | Yoshihiko Fujita |
collection | DOAJ |
description | The tissue distribution and function of hemoglobin or myoglobin are well known; however, a newly found cytoglobin (CYGB), which also belongs to the globin family, remains to be characterized. To assess its expression in human malignancies, we sought to screen a number of cell lines originated from many tissues using northern blotting and real time PCR techniques. Unexpectedly, we found that several, but not all, melanoma cell lines expressed CYGB mRNA and protein at much higher levels than cells of other origins. Melanocytes, the primary origin of melanoma, also expressed CYGB at a high level. To verify these observations, immunostaining and immunoblotting using anti-CYGB antibody were also performed. Bisulfite-modified genomic sequencing revealed that several melanoma cell lines that abrogated CYGB expression were found to be epigenetically regulated by hypermethylation in the promoter region of CYGB gene. The RNA interference-mediated knockdown of the CYGB transcript in CYGB expression-positive melanoma cell lines resulted in increased proliferation in vitro and in vivo. Flow cytometric analysis using 2'-, 7'-dichlorofluorescein diacetate (DCFH-DA), an indicator of reactive oxygen species (ROS), revealed that the cellular ROS level may be involved in the proliferative effect of CYGB. Thus, CYGB appears to play a tumor suppressive role as a ROS regulator, and its epigenetic silencing, as observed in CYGB expression-negative melanoma cell lines, might function as an alternative pathway in the melanocyte-to-melanoma transition. |
first_indexed | 2024-04-12T12:21:51Z |
format | Article |
id | doaj.art-22fa673e76824fd8ac4cb9e67a044f3d |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-12T12:21:51Z |
publishDate | 2014-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-22fa673e76824fd8ac4cb9e67a044f3d2022-12-22T03:33:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9477210.1371/journal.pone.0094772Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin.Yoshihiko FujitaSatoshi KoinumaMarco A De VelascoJan BolzYosuke TogashiMasato TerashimaHidetoshi HayashiTakuya MatsuoKazuto NishioThe tissue distribution and function of hemoglobin or myoglobin are well known; however, a newly found cytoglobin (CYGB), which also belongs to the globin family, remains to be characterized. To assess its expression in human malignancies, we sought to screen a number of cell lines originated from many tissues using northern blotting and real time PCR techniques. Unexpectedly, we found that several, but not all, melanoma cell lines expressed CYGB mRNA and protein at much higher levels than cells of other origins. Melanocytes, the primary origin of melanoma, also expressed CYGB at a high level. To verify these observations, immunostaining and immunoblotting using anti-CYGB antibody were also performed. Bisulfite-modified genomic sequencing revealed that several melanoma cell lines that abrogated CYGB expression were found to be epigenetically regulated by hypermethylation in the promoter region of CYGB gene. The RNA interference-mediated knockdown of the CYGB transcript in CYGB expression-positive melanoma cell lines resulted in increased proliferation in vitro and in vivo. Flow cytometric analysis using 2'-, 7'-dichlorofluorescein diacetate (DCFH-DA), an indicator of reactive oxygen species (ROS), revealed that the cellular ROS level may be involved in the proliferative effect of CYGB. Thus, CYGB appears to play a tumor suppressive role as a ROS regulator, and its epigenetic silencing, as observed in CYGB expression-negative melanoma cell lines, might function as an alternative pathway in the melanocyte-to-melanoma transition.http://europepmc.org/articles/PMC3983271?pdf=render |
spellingShingle | Yoshihiko Fujita Satoshi Koinuma Marco A De Velasco Jan Bolz Yosuke Togashi Masato Terashima Hidetoshi Hayashi Takuya Matsuo Kazuto Nishio Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin. PLoS ONE |
title | Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin. |
title_full | Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin. |
title_fullStr | Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin. |
title_full_unstemmed | Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin. |
title_short | Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin. |
title_sort | melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes a novel expression site of cytoglobin |
url | http://europepmc.org/articles/PMC3983271?pdf=render |
work_keys_str_mv | AT yoshihikofujita melanomatransitionisfrequentlyaccompaniedbyalossofcytoglobinexpressioninmelanocytesanovelexpressionsiteofcytoglobin AT satoshikoinuma melanomatransitionisfrequentlyaccompaniedbyalossofcytoglobinexpressioninmelanocytesanovelexpressionsiteofcytoglobin AT marcoadevelasco melanomatransitionisfrequentlyaccompaniedbyalossofcytoglobinexpressioninmelanocytesanovelexpressionsiteofcytoglobin AT janbolz melanomatransitionisfrequentlyaccompaniedbyalossofcytoglobinexpressioninmelanocytesanovelexpressionsiteofcytoglobin AT yosuketogashi melanomatransitionisfrequentlyaccompaniedbyalossofcytoglobinexpressioninmelanocytesanovelexpressionsiteofcytoglobin AT masatoterashima melanomatransitionisfrequentlyaccompaniedbyalossofcytoglobinexpressioninmelanocytesanovelexpressionsiteofcytoglobin AT hidetoshihayashi melanomatransitionisfrequentlyaccompaniedbyalossofcytoglobinexpressioninmelanocytesanovelexpressionsiteofcytoglobin AT takuyamatsuo melanomatransitionisfrequentlyaccompaniedbyalossofcytoglobinexpressioninmelanocytesanovelexpressionsiteofcytoglobin AT kazutonishio melanomatransitionisfrequentlyaccompaniedbyalossofcytoglobinexpressioninmelanocytesanovelexpressionsiteofcytoglobin |